Previously, we speculated that the structure of the LH-type hEx3-Db was capable of avoiding steric hindrance with cell surface molecules, and this might contribute to its superior cancer growth inhibition effect, independent of target affinity. The gene discussed is PLOD1; the disease is cancer.